Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

A novel antigen design strategy to isolate single‐domain antibodies that target human Naᵥ1.7 and reduce pain in animal models

Title: A novel antigen design strategy to isolate single‐domain antibodies that target human Naᵥ1.7 and reduce pain in animal models
Authors: Martina, Marzia; Banderali, Umberto; Yogi, Alvaro; Arbabi Ghahroudi, Mehdi; Liu, Hong; Sulea, Traian; Durocher, Yves; Hussack, Greg; van Faassen, Henk; Chakravarty, Balu; Liu, Qing Yan; Iqbal, Umar; Ling, Binbing; Lessard, Etienne; Sheff, Joey; Robotham, Anna; Callaghan, Debbie; Moreno, Maria; Comas, Tanya; Ly, Dao; Stanimirovic, Danica
Publisher Information: Wiley
Publication Year: 2024
Collection: National Research Council Canada: NRC Publications Archive
Subject Terms: automated patch-clamp system; epitope; mouse OD1 model; pain; rat Hargreaves model; surface plasmon resonance; VₕH
Description: Genetic studies have identified the voltage-gated sodium channel 1.7 (Naᵥ1.7) as pain target. Due to the ineffectiveness of small molecules and monoclonal antibodies as therapeutics for pain, single-domain antibodies (VₕHs) are developed against the human Naᵥ1.7 (hNaᵥ1.7) using a novel antigen presentation strategy. A 70 amino-acid peptide from the hNaᵥ1.7 protein is identified as a target antigen. A recombinant version of this peptide is grafted into the complementarity determining region 3 (CDR3) loop of an inert VₕH in order to maintain the native 3D conformation of the peptide. This antigen is used to isolate one VₕH able to i) bind hNaᵥ1.7, ii) slow the deactivation of hNaᵥ1.7, iii) reduce the ability of eliciting action potentials in nociceptors, and iv) reverse hyperalgesia in in vivo rat and mouse models. This VₕH exhibits the potential to be developed as a therapeutic capable of suppressing pain. This novel antigen presentation strategy can be applied to develop biologics against other difficult targets such as ion channels, transporters and GPCRs. ; Peer reviewed: Yes ; NRC publication: Yes
Document Type: article in journal/newspaper
File Description: text
Language: English
ISSN: 2198-3844
Relation: Advanced Science, Publication date: 2024-08-24
DOI: 10.1002/advs.202405432
Availability: https://doi.org/10.1002/advs.202405432; https://nrc-publications.canada.ca/eng/view/ft/?id=35b1e016-2737-40e4-bcb7-08672dd850ed; https://nrc-publications.canada.ca/eng/view/object/?id=35b1e016-2737-40e4-bcb7-08672dd850ed; https://nrc-publications.canada.ca/fra/voir/objet/?id=35b1e016-2737-40e4-bcb7-08672dd850ed
Rights: Creative Commons Attribution 4.0 International (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/) ; Creative Commons Attribution 4.0 International (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/deed.fr)
Accession Number: edsbas.E3DD1BB4
Database: BASE